cdmo.directory
← Compare landing

Merck KGaA vs Yongtai Technology

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryMerck KGaAYongtai Technology
SummaryRecent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.Yongtai Technology is a chemical manufacturing and contract services provider based in Linhai, Zhejiang, operating pharmaceutical, agrochemical, and materials business divisions with capabilities in API synthesis and chemical manufacturing.
ServicesData not yet provided.
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
ModalitiesData not yet provided.Data not yet provided.
Development capabilitiesData not yet provided.Data not yet provided.
Manufacturing capabilitiesData not yet provided.Data not yet provided.
Locations
  • Daejeon Bioprocessing Center, Daejeon, South Korea
  • Headquarters, Linhai, Zhejiang, China
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Merck KGaA alternatives · Yongtai Technology alternatives

Markdown mirror: /compare/merck-kgaa/yongtaitech.md